Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1307 of 5804
-
AI-Powered ECG could spare thousands from invasive heart tests
Diagnosis Recruiting nowAngina pectoris is diagnosed in \>180.000 people in the Netherlands each year. Diagnosis in angina pectoris focuses on epicardial coronary stenosis, the identification of which may lead to guideline-directed medical therapy or revascularization. However, no such stenosis is ident…
Phase: NA • Sponsor: UMC Utrecht • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Newborn DNA screening could slash time to rare disease diagnosis
Knowledge-focused Recruiting nowThe main objective of the genetic newborn screening part of the Screen4Care-project is to shorten the path to rare disease diagnosis and to facilitate early intervention. Therefore, genetic newborn screening for currently treatable rare diseases (TREAT-panel approach) will be off…
Phase: NA • Sponsor: University Hospital Freiburg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New weekly shot could protect kidneys in people with obesity
Disease control Recruiting nowThe study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney function in participants with chronic kidney disease with or without type 2 diabetes, living with overweight or obesity. The participant…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
One pill to tackle two heart risks: new combo drug enters final testing
Disease control Recruiting nowA Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 14:50 UTC
-
Robot-Assisted rehab could speed recovery for severe brain injury patients
Disease control Recruiting nowIn the rehabilitation project for patients with severe Acquired Brain Injury (sABI), it is essential to include exercises that facilitate the recovery of the upright position (or verticalization). Recently, tilt-table equipped with the robot-assisted lower limbs cyclic mobilizati…
Phase: NA • Sponsor: Anna Estraneo • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Virtual walking therapy tested for spinal cord injury pain
Symptom relief Recruiting nowThe purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with incomplete spinal cord injury.
Phase: NA • Sponsor: Texas A&M University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug ivonescimab tested for tough cancers
Disease control Recruiting nowTo learn if ivonescimab can help to control advanced cSCC. The safety and effects of ivonescimab will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New RNA vaccine trial targets deadly brain tumors
Disease control Recruiting nowThis is a Phase I study to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in adult patients with recurrent glioblastoma.
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could an ALS drug clear the fog of chemo brain?
Symptom relief Recruiting nowThis is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels in cancer survivors (recently completing prior treatment regimens) or patients who have…
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare blood disorder
Knowledge-focused Recruiting nowImmune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and ischemic organ damage due to microvascular thrombosis. It results from a severe deficiency in the von Willeband …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
AI takes on liver cancer: smart dosing trial launches
Disease control Recruiting nowThis study will test the hypothesis that a novel combination of three drugs (sorafenib, sonidegib, and irinotecan), in conjunction with individually optimized doses, can be safely administered and lead to improved clinical outcomes in patients with hepatocellular carcinoma compar…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
AI could speed up radiation planning by automatically mapping healthy tissues
Knowledge-focused Recruiting nowThis study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiation therapy planning.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Weight loss could be key to spotting lung cancer sooner
Diagnosis Recruiting nowThe researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Balance-Restoring implant shows promise for dizziness sufferers
Disease control Recruiting nowAlthough cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a new scan unlock better breast cancer treatment?
Diagnosis Recruiting nowA strategy to target the oncogenic receptor HER2 using a version of the anti-HER2 therapeutic antibody trastuzumab coupled to desferrioxamine (DFO) and radiolabeled with zirconium-89 (\[89Zr\]-DFO-trastuzumab) has been successfully evaluated in our group in preclinical settings. …
Phase: PHASE1, PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Spinal implant aims to restore bladder and bowel control after paralysis
Disease control Recruiting nowThis clinical trial aims to evaluate the safety and efficacy of spinal cord stimulation (SCS) in treating patients with urinary and bowel dysfunction after spinal cord injury (SCI). SCI is a highly disabling condition that can lead to sensory, motor, and autonomic nervous system …
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Immune cells engineered to hunt cancer: new trial for hard-to-treat blood cancers
Disease control Recruiting nowCD70 is a promising target for immunotherapy because it is overexpressed in T-cell lymphoma (TCL) and acute myeloid leukemia (AML) tumor cells but is found in deficient levels in normal tissues and hematopoietic stem cells. This study aims to evaluate the safety and efficacy of C…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New scan may tell rectal cancer patients if they can skip surgery
Knowledge-focused CompletedThe combination of short course radiotherapy and immunotherapy helps to increase the proportion of pathological complete response after neoadjuvant therapy, providing more patients with the opportunity for organ preservation. However, there is no accurate and unified cCR diagnost…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
5,000 couples join study to uncover hidden factors in IVF success
Knowledge-focused Recruiting nowThis large-scale study aims to understand how everyday environment and lifestyle may affect the success of fertility treatments like IVF. The main idea is that exposure to certain environmental chemicals (e.g., from plastics or air pollution) and personal habits (e.g., diet, stre…
Sponsor: The Third Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Cool roofs may cool minds: trial targets Heat-Driven anxiety
Disease control OngoingAmbient air temperatures in India have broken record highs. Solutions are needed to build heat resilience in communities and adapt to increasing heat from climate change. Sunlight-reflecting cool roof coatings may passively reduce indoor temperatures and energy use to protect hom…
Phase: NA • Sponsor: Aditi Bunker • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC